Association of circulating tumor DNA from the cerebrospinal fluid with high‐risk CNS involvement in patients with diffuse large B‐cell lymphoma
Authors:
Open Access
- 15 January 2021
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (1) , e236
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81970176)
- Natural Science Foundation of Guangdong Province (2019A1515011943)
This publication has 9 references indexed in Scilit:
- Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastasesAnnals of Oncology, 2019
- CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOPJournal of Clinical Oncology, 2016
- Prevention of CNS relapse in diffuse large B-cell lymphomaThe Lancet Oncology, 2011
- Double-hit B-cell lymphomasBlood, 2011
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapyBlood, 2009
- Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-upAnnals of Oncology, 2007
- Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)Annals of Oncology, 2006
- Incidence and risk factors for central nervous system occurrencein elderly patients with diffuse large-B-cell lymphoma: influenceof rituximabAnnals of Oncology, 2004
- Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patientsAnnals of Oncology, 2000